Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02834572 · ClinicalTrials.gov registry record · NA
Using Technology to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options
A NA study, sponsored by New York Blood Center.
- Terminated
- Registry status
- NA
- Development phase
- 236
- Enrollment target
NCT02834572: Clinical Trial NA study, sponsored by New York Blood Center.
NCT02834572 is a NA study that was terminated before completion, run by New York Blood Center. The registered enrollment target is 236 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02834572, a NA study, was terminated before completion, sponsored by New York Blood Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 236 participants
- Enrollment target
Study Summary
Young Black men who have sex with men (MSM) and transwomen in the US are affected by HIV at severely disproportionate rates. A key component of HIV prevention for communities at risk is diagnosing HIV infections through regular HIV testing. A significant proportion of young Black MSM and transwomen have not tested in the prior year. This research study seeks to address low HIV testing rates among young Black MSM and transwomen by testing a brief Internet-based HIV testing intervention optimized for mobile devices. The intervention takes advantage of the variety of HIV testing options now available, including the HIV self testing, couples-based HIV counseling and testing and traditional clinic-based testing and will provide men and transwomen with a tailored recommendation of their optimal HIV testing approach. The investigators are conducting a pilot randomized study among young Black MSM and transwomen followed for 6 months to estimate the intervention's potential efficacy in increasing HIV testing.
Primary Outcome
Self-reported HIV test in the prior 3 months assessed by questionnaire
Interventions
- BEHAVIORAL Control
- BEHAVIORAL All About Me
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 236 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-12 |
| Phase | NA |
Why NCT02834572 stopped before completion
NCT02834572 is an interventional study that assigns participants to a tested intervention. The registered 236 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT02834572 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02834572 about?
NCT02834572 is a clinical study titled "Using Technology to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options". Young Black men who have sex with men (MSM) and transwomen in the US are affected by HIV at severely disproportionate rates. A key component of HIV prevention for communities at risk is diagnosing HIV infections through regular HIV testing. A significant proportion of young Black MSM and transwomen ...
What is the current status of trial NCT02834572?
This trial is currently terminated. It is a NA study. The enrollment target is 236 participants. The study started on 2016-06. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02834572?
The interventions under investigation include: Control (BEHAVIORAL), All About Me (BEHAVIORAL).
Who is sponsoring clinical trial NCT02834572?
This trial is sponsored by New York Blood Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02834572's enrollment target sits among peer trials
236 461st of 2000 higher than 1,540 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04995341 · 236 participants · NA
Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
- NCT05822362 · 236 participants · Phase 2
CBD for Individuals at Risk for Alzheimer's Disease
- NCT06200103 · 236 participants · Phase 2
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
- NCT06494072 · 236 participants · Phase 4
Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia